The healthcare industry is undergoing rapid transformation, driven by innovation, patient-centric solutions, and global demand for reliable medicines. Among the trusted names in this space, Amanta Healthcare Ltd has earned a strong reputation as a leading manufacturer of sterile solutions and pharmaceutical formulations, catering to both domestic and international markets.
About the Company
Founded with the vision to provide world-class healthcare solutions, Amanta Healthcare Ltd is a prominent player in the parenteral (injectable) pharmaceutical segment. The company specializes in producing Large Volume Parenterals (LVPs), Small Volume Parenterals (SVPs), eye/ear drops, and other sterile products. With state-of-the-art facilities and advanced technology, Amanta ensures high standards of safety, efficacy, and quality in every product.
Core Strengths of Amanta Healthcare Ltd
- Specialized Expertise – Strong focus on sterile solutions, ensuring reliability in life-saving treatments.
- Global Presence – Products are exported to more than 80 countries, making Amanta a recognized Indian healthcare exporter.
- Quality Certifications – Compliance with international regulatory standards such as WHO-GMP, EU-GMP, and ISO certifications.
- Research & Innovation – Continuous investment in R&D for developing advanced drug delivery systems and cost-effective healthcare solutions.
- Wide Therapeutic Coverage – Products catering to critical care, nephrology, gastroenterology, anti-infectives, and supportive therapies.
Industry Position
The global injectables and parenterals market is witnessing strong growth due to rising demand for hospitalization, chronic disease management, and advanced drug delivery methods. In this landscape, Amanta Healthcare Ltd stands out as a reliable partner to hospitals, healthcare institutions, and distributors worldwide.
Growth & Future Outlook
Amanta Healthcare Ltd is expanding its footprint by:
- Strengthening partnerships in regulated markets (Europe, Latin America, Southeast Asia, and Africa).
- Innovating in specialized dosage forms and patient-friendly packaging.
- Enhancing manufacturing capabilities with automation and quality-driven practices.
With its global vision, strong infrastructure, and commitment to quality, Amanta Healthcare is well-positioned to grow as a global healthcare leader in the years ahead.
Amanta Healthcare Ltd. IPO Timetable
Particular | Date |
IPO Open Date | 01 Sep 2025 |
IPO Close Date | 03 Sep 2025 |
Allotment Date | 04 Sep 2025 |
IPO Listing Date | 09 Sep 2025 |
Amanta Healthcare Ltd. IPO Details
Issue Type | Bookbuilding IPO |
Face Value | Rs. 10 Per Equity Share |
IPO Price | Rs. 120 to 126 Per Equity Share |
Market Lot | 119 Share |
ISIN Code | |
Listing At | NSE, BSE |
Issue Size | Approx. Rs. 126 Crore. |
Amanta Healthcare Ltd. IPO Lot Size
Application | Lots | Shares | Amount |
Minimum | 1 | 119 | Rs. 14994 |
Maximum | 13 | 1547 | Rs. 194922 |
Small HNI (Minimum) | 14 | 1666 | Rs. 209916 |
Big HNI (Minimum) | 70 | 7973 | Rs. 1004598 |
Amanta Healthcare Ltd. IPO Allotment Status
Click Here To Check IPO Allotment Status Amanta Healthcare Ltd. IPO
Click Here To Get ASBA Forms Amanta Healthcare Ltd. IPO
Company Financials :
Particular | 31 March 2025 | 31 March 2024 | 31 March 2023 |
Total Assets | 381.76 | 352.12 | 374.06 |
Total Revenue | 276.09 | 281.61 | 262.70 |
Profit After Tax | 10.50 | 3.63 | -2.11 |
Company Promoters:
The promoters of the Company are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited.
Objects of this Issue:
- Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat & SVP at Hariyala, Kheda, Gujarat
- General Corporate Purposes.
Registrar & Company Details
Company Contact Information | IPO Registrar |
Amanta Healthcare Ltd. 8th Floor, Shaligram Corporates C.J. Marg Ambli, Ahmedabad, Gujarat, 380058 Phone: 079 67777600 Email: cs@amanta.co.in Website: https://www.amanta.co.in/ | MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: amantahealthcare.ipo@linkintime.co.in Website: https://linkintime.co.in/Initial_Offer/public-issues.html |